Applications for Pharmaceutical and Medical Device Companies
The Archimedes Model enables pharmaceutical, biotechnology and medical device companies to study and understand the effects of their products and programs in a variety of environments ranging from controlled trials to realistic healthcare delivery systems. The Model helps companies to prioritize their programs to maximize the effect on health and financial outcomes for the company and its customers.
The Archimedes Model provides companies with a simulated environment for answering complex questions far more rapidly and inexpensively than would otherwise be possible.
Specific uses of the Model include:
- Determining the potential value of a device or drug in different populations
- Determining optimal target populations for achieving specified clinical objectives
- Understanding quantitatively the benefits and risks of different clinical uses of a drug
- Extending clinical trials and evaluating additional outcomes such as utilization and costs
- Determining the effects on market size, outcomes and costs of new guidelines
- Comparing the effectiveness of two or more interventions
- Identifying optimal populations and indications for diagnostic tests
- Planning and setting priorities
- Conducting cost-effectiveness analysis
- Determine the ROI for educational and medical programs
- Understanding the effects on outcomes and costs of changes in patient adherence and compliance
Archimedes works with pharmaceutical, biotechnology and medical device companies to fundamentally change how decisions are made by outcomes analysts, brand teams and executives in the industry.